Alburae Najla Ali, Mohammed Afrah E, Alorfi Hajer Saeed, JamanTurki Adnan, Asfour Hani Zakaria, Alarif Walied Mohamed, Abdel-Lateff Ahmed
Department of Biology, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia,
Department of Biology, Faculty of Science, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia,
Metabolites. 2020 Feb 17;10(2):73. doi: 10.3390/metabo10020073.
The genus (Ascomycota) includes more than thirty species with worldwide distribution across many ecosystems. It is considered a rich source of diverse metabolites. The published classes of natural compounds that are discussed here are organized according to the following biosynthetic pathways: polyketides (azaphilones, cyclopentenone pigments, dicyanides, furan derivatives, phenolic ethers, and xanthones and anthraquinones); shikimate derivatives (bicoumarins); mevalonate derivatives (meroterpenes, sesquiterpenes, sesterterpenes and steroids) and amino acids derivatives (alkaloids (indole-derivatives, isoindolones, and piperazine) and peptides (depsipeptides)). These metabolites produce the wide array of biological effects associated with , including antioxidant, antiproliferative, antimalarial, antiviral, antibacterial, antioxidant, antihypertensive, anti-inflammatory, antifungal and kinase inhibitors. Careful and extensive study of the diversity and distribution of metabolites produced by the genus (either marine or terrestrial) revealed that, no matter the source of the fungus, the composition of the culture medium effectively controls the metabolites produced. The topic of this review is the diversity of metabolites that have been identified from , along with the contextual information on either their biological or geographic sources. This review presents 236 natural compounds, which were reported from marine and terrestrial . Amongst the reported compounds, only 70.2% were biologically assayed for their effects, including antimicrobial or cytotoxicity. This implies the need for substantial investigation of alternative activities. This review includes a full discussion of compound structures and disease management, based on materials published from 1982 through December 2019.
属(子囊菌门)包括三十多种,分布于全球许多生态系统。它被认为是多种代谢产物的丰富来源。本文讨论的已发表天然化合物类别按以下生物合成途径分类:聚酮化合物(氮杂环庚三烯酮、环戊烯酮色素、二氰化物、呋喃衍生物、酚醚以及呫吨酮和蒽醌);莽草酸衍生物(双香豆素);甲羟戊酸衍生物(半萜、倍半萜、链状四萜和类固醇)以及氨基酸衍生物(生物碱(吲哚衍生物、异吲哚酮和哌嗪)和肽(缩肽))。这些代谢产物产生了与属相关的广泛生物效应,包括抗氧化、抗增殖、抗疟疾、抗病毒、抗菌、抗氧化、抗高血压、抗炎、抗真菌和激酶抑制作用。对属(海洋或陆地)产生的代谢产物的多样性和分布进行仔细而广泛的研究表明,无论真菌来源如何,培养基的组成有效地控制了所产生的代谢产物。本综述的主题是从属中鉴定出的代谢产物的多样性,以及它们的生物或地理来源的背景信息。本综述介绍了236种天然化合物,这些化合物是从海洋和陆地的属中报道的。在报道的化合物中,只有70.2%进行了生物活性测试,包括抗菌或细胞毒性。这意味着需要对替代活性进行大量研究。本综述基于1982年至2019年12月发表的材料,对化合物结构和疾病管理进行了全面讨论。